William Spencer to Ethanol
This is a "connection" page, showing publications William Spencer has written about Ethanol.
Connection Strength
1.983
-
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol. 2011 Nov 22; 58(22):2322-8.
Score: 0.248
-
Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008 Oct; 1(5):561-70.
Score: 0.200
-
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures. Clin Cardiol. 2003 Jun; 26(6):275-9.
Score: 0.138
-
Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am Heart Hosp J. 2003; 1(1):83-90.
Score: 0.134
-
Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy. Cardiol Rev. 2002 Mar-Apr; 10(2):108-18.
Score: 0.127
-
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Nov 15; 38(6):1701-6.
Score: 0.124
-
Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001 Mar 20; 103(11):1492-6.
Score: 0.119
-
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000 Sep; 36(3):852-5.
Score: 0.114
-
Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry. Circulation. 2000 Aug 08; 102(6):600-1.
Score: 0.114
-
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998 Oct 27; 98(17):1750-5.
Score: 0.100
-
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998 Jul; 32(1):225-9.
Score: 0.098
-
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
Score: 0.050
-
Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Aug 21; 50(8):795-8.
Score: 0.046
-
Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2005 Dec; 28(12):1354-6.
Score: 0.041
-
Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15; 96(4):580-1.
Score: 0.040
-
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Card Fail. 2005 Mar; 11(2):124-30.
Score: 0.039
-
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol. 2005 Mar; 28(3):124-30.
Score: 0.039
-
Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 24; 109(7):824-7.
Score: 0.036
-
Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 10; 109(5):e27-8.
Score: 0.036
-
Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy. Am Heart J. 2003 Dec; 146(6):1112-4.
Score: 0.036
-
Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol. 2002 Nov-Dec; 9(6):594-600.
Score: 0.033
-
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Jan; 37(1):208-14.
Score: 0.029
-
Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec; 20(6):559-63.
Score: 0.012
-
Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol. 2007 Nov 15; 100(10):1592-7.
Score: 0.012
-
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 05; 42(9):1687-713.
Score: 0.009
-
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003 Jul 16; 42(2):296-300.
Score: 0.009